tiprankstipranks
Trending News
More News >

Merit Medical price target raised to $108 from $106 at Wells Fargo

Wells Fargo raised the firm’s price target on Merit Medical (MMSI) to $108 from $106 and keeps an Overweight rating on the shares. The firm notes the company has announced it acquired hemostasis products, StatSeal and WoundSeal, from BioLife for $120M in cash or about 6.7-times forward year sales. The deal is expected to add $10M-$11M in revenue and be a penny dilutive to EPS in FY25.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue